Description
PT-141, also known as bremelanotide, is a synthetic cyclic peptide and melanocortin receptor agonist. It is primarily studied for its interaction with central nervous-system pathways involved in sexual desire and arousal, particularly the MC3 and MC4 melanocortin receptors.
Bremelanotide has been evaluated in clinical research involving sexual-function pathways in both women and men. An FDA-approved prescription formulation is available in the United States for certain premenopausal women with acquired, generalised hypoactive sexual desire disorder
Reviews
There are no reviews yet.